Your browser doesn't support javascript.
loading
In Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein Formulations.
Chisholm, Carly Fleagle; Nguyen, Bao Han; Soucie, Kaitlin R; Torres, Raul M; Carpenter, John F; Randolph, Theodore W.
Afiliación
  • Chisholm CF; Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309.
  • Nguyen BH; Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309.
  • Soucie KR; Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309.
  • Torres RM; Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado 80045.
  • Carpenter JF; Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045.
  • Randolph TW; Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309. Electronic address: Theodore.randolph@colorado.edu.
J Pharm Sci ; 104(11): 3681-3690, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26190624
Subvisible particles in a therapeutic protein product may act as adjuvants to promote unwanted immune responses against the protein. Silicone oil is used as a lubricant in prefilled syringes, and microdroplets of silicone oil are often detected in protein formulations expelled from prefilled syringes. In order to test the adjuvant potency of silicone oil microdroplets, antibody responses in mice to subcutaneous injections of formulations of ovalbumin (OVA) that contained silicone oil microdroplets were measured. These responses were compared against responses to oil-free OVA formulations and to OVA formulations that contained microparticulate aluminum hydroxide ("alum"), the common vaccine adjuvant. When administered with high concentrations of silicone oil microdroplets, OVA formulations elicited strong anti-OVA IgG1 and IgG2a antibody responses. These responses were equivalent to those observed when alum microparticles were added to OVA formulations, suggesting that silicone oil can act as a potent adjuvant. However, when OVA formulations were prepared with lower levels of silicone oil that had been obtained directly from commercial siliconized syringes, the anti-OVA antibody response was not enhanced significantly compared with responses against OVA alone.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aceites de Silicona / Ovalbúmina / Adyuvantes Inmunológicos / Formación de Anticuerpos Idioma: En Revista: J Pharm Sci Año: 2015 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aceites de Silicona / Ovalbúmina / Adyuvantes Inmunológicos / Formación de Anticuerpos Idioma: En Revista: J Pharm Sci Año: 2015 Tipo del documento: Article